← Back to Search

Other

BTL-785-7 for Wrinkles

N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a non-surgical device to reduce facial wrinkles. It targets people with facial wrinkles and works by using energy to boost skin proteins for smoother skin.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Histological examination
Secondary study objectives
Evaluation of Overall Facial Appearance According to GAIS
Evaluation of Wrinkle Severity
Subject Satisfaction
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Subjects will be enrolled for an active treatment with BTL-785F device (BTL-785-7 applicator) for non-invasive facial rejuvenation.
Group II: ControlActive Control1 Intervention
One subject will serve as a control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2022
N/A
~160

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
53 Previous Clinical Trials
1,861 Total Patients Enrolled
13 Trials studying Wrinkles
400 Patients Enrolled for Wrinkles
~2 spots leftby Nov 2025